Kim_2016_Eur.J.Pharmacol_771_65

Reference

Title : Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes - Kim_2016_Eur.J.Pharmacol_771_65
Author(s) : Kim TH , Kim MK , Cheong YH , Chae YN , Lee Y , Ka SO , Jung IH , Shin CY , Bae EJ , Son MH
Ref : European Journal of Pharmacology , 771 :65 , 2016
Abstract : Kim_2016_Eur.J.Pharmacol_771_65
ESTHER : Kim_2016_Eur.J.Pharmacol_771_65
PubMedSearch : Kim_2016_Eur.J.Pharmacol_771_65
PubMedID: 26621343

Related information

Citations formats

Kim TH, Kim MK, Cheong YH, Chae YN, Lee Y, Ka SO, Jung IH, Shin CY, Bae EJ, Son MH (2016)
Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes
European Journal of Pharmacology 771 :65

Kim TH, Kim MK, Cheong YH, Chae YN, Lee Y, Ka SO, Jung IH, Shin CY, Bae EJ, Son MH (2016)
European Journal of Pharmacology 771 :65